ngs across tumor types for trk inhibition
Published 6 years ago • 50 plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
4:40
use of trk inhibition in specific tumor types
-
5:08
challenges with ngs for trk inhibition
-
6:17
optimal use of ngs for trk inhibition
-
4:41
trk inhibitors for solid tumors: overview
-
6:16
next-generation sequencing for trk inhibition
-
2:33
advocating for early ngs testing to identify trk fusion
-
4:36
trk inhibition: personal experience with larotrectinib
-
6:24
the importance and evolution of ngs testing
-
5:20
trk inhibitor in gi cancers: adverse effect profile
-
4:16
comprehensive ngs and screening for trk gene fusion
-
4:07
trk inhibition: ongoing challenges
-
3:54
managing patients on trk inhibitors
-
50:46
selective, potent, different: next-generation ros1 and trk inhibition in nsclc and other tumors
-
6:48
trk inhibition’s potential role in clinical practice
-
5:15
role of ntrk inhibitors
-
2:49
larotrectinib: the first fda-approved trk inhibitor
-
6:02
early development of trk inhibitor–larotrectinib
-
3:21
drawing larotrectinib data from different tumor types
-
6:00
efficacy of trk inhibitors